BBLG
NASDAQ
$1.12
Bone Biologics Corp (BBLG)
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using recombinant human protein. The company is headquartered in Burlington, Massachusetts.
This company is also listed under the following ticker: BBLGW.
Website: https://www.bonebiologics.comSector:
Healthcare
Industry:
Biotechnology
Target: $12.20 (+989.29%)
Market Cap
$2.23M
P/B Ratio
0.47
FCF 5Y CAGR
+44.70%
Beta (5Y)
0.80
Price Chart
Valuation
Market Cap$2.23M
P/B0.47
Profitability
EBITDA-$2.86M
Profit Margin0%
Operating Margin0%
EPS-$1.62
Growth & Risk
EPS 5Y CAGR-27.24%
FCF 5Y CAGR+44.70%
Beta (5Y)0.80
Sharpe Ratio-0.93